Position in RCUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,637,625
+$240,020 QoQ
Shares Held
75,816
+29.3% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. RCUS ranks #145 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in RCUS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,637,625 | 75,816 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,397,605 | 58,649 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $671,051 | 49,342 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $361,163 | 44,369 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $267,457 | 34,071 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $460,815 | 30,948 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $568,986 | 37,213 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $555,864 | 36,498 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $656,344 | 34,764 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $627,587 | 32,858 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $560,273 | 31,213 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,719,702 | 281,620 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,098,626 | 279,530 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,458,847 | 505,747 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $625,197 | 23,899 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $448,543 | 17,701 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $613,431 | 19,437 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $720,973 | 17,815 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $648,024 | 18,584 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $511,387 | 18,623 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $596,278 | 21,235 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $551,494 | 21,244 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $195,430 | 11,402 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||